Moreover, BMDCs exposed to DACT‐treated tumor cells upregulated MHC class II and the co‐stimulatory molecule and activation marker CD86 (Fig 4A, C and D, Appendix Fig S4). The gene discussed is CD86; the disease is neoplasm.